AU6111896A - Test of hiv-specific t lymphocyte function that detects expo sure to hiv antigens and possibly early hiv infection - Google Patents

Test of hiv-specific t lymphocyte function that detects expo sure to hiv antigens and possibly early hiv infection

Info

Publication number
AU6111896A
AU6111896A AU61118/96A AU6111896A AU6111896A AU 6111896 A AU6111896 A AU 6111896A AU 61118/96 A AU61118/96 A AU 61118/96A AU 6111896 A AU6111896 A AU 6111896A AU 6111896 A AU6111896 A AU 6111896A
Authority
AU
Australia
Prior art keywords
hiv
detects
test
specific
lymphocyte function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61118/96A
Inventor
Jay A. Berzofsky
Mario Clerici
Gene M Shearer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU6111896A publication Critical patent/AU6111896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU61118/96A 1995-06-07 1996-06-07 Test of hiv-specific t lymphocyte function that detects expo sure to hiv antigens and possibly early hiv infection Abandoned AU6111896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48843595A 1995-06-07 1995-06-07
US488435 1995-06-07
PCT/US1996/010108 WO1996041189A1 (en) 1995-06-07 1996-06-07 Test of hiv-specific t lymphocyte function that detects exposure to hiv antigens and possibly early hiv infection

Publications (1)

Publication Number Publication Date
AU6111896A true AU6111896A (en) 1996-12-30

Family

ID=23939696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61118/96A Abandoned AU6111896A (en) 1995-06-07 1996-06-07 Test of hiv-specific t lymphocyte function that detects expo sure to hiv antigens and possibly early hiv infection

Country Status (2)

Country Link
AU (1) AU6111896A (en)
WO (1) WO1996041189A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0108210A (en) * 2000-02-04 2002-10-22 Univ Duke Vaccine against human immunodeficiency virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081226A (en) * 1986-12-30 1992-01-14 The United States Of America As Represented By The Department Of Health And Human Services Synthetic peptides sharing sequence homology with the HIV envelope protein

Also Published As

Publication number Publication date
WO1996041189A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
PL329930A1 (en) Antigens of human lymphocytes b and related reagents
AU4958590A (en) Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
AU4750390A (en) Virus inactivated blood product and method
AU6905596A (en) Blood collection and testing device
AU4087696A (en) Detection and sorting of materials
AU2611492A (en) Improved device and method of separating and assaying whole blood
AU2391195A (en) Lymphocyte activation antigens and antibodies thereto
AU1165097A (en) Sampling and assay device
AU6929491A (en) Device and method of separating and assaying whole blood
AU1689497A (en) Methods of culturing and assaying a virus
AU3834089A (en) An exhaust silencer
AU7400998A (en) A new EIA test using non-dentured HIV antigen for early detection of HIV in fection
AU3238995A (en) Hepatitis a virus receptor and methods of use
AU2508095A (en) Cycloolefin copolymers and a process for their preparation
AU2989495A (en) Separation of human serum albumin
AU6111896A (en) Test of hiv-specific t lymphocyte function that detects expo sure to hiv antigens and possibly early hiv infection
AU5441190A (en) Device for separating fibres and gas
AU1334588A (en) Assay for detecting hepatitis antigens and aids antibodies
AU2507995A (en) Cycloolefin copolymers and a process for their preparation
GB9710875D0 (en) Assay for detecting HIV antigens and HIV antibodies
AU5776896A (en) Means for detecting and preventing HIV infection involving use of receptors or binding sites capable of interacting with GP120
EP0870509A4 (en) Sugar chain-recognizing antibody and remedy for infection with hiv
AU1075197A (en) Efficient method of detecting an infectious agent in blood
AU6969096A (en) Monoclonal lymphocytes and methods of use
AU5100696A (en) Specific hiv-1 group o antigens